Phase II randomized study of oral uracil/tegafur (UFT) plus leucovorin (LV) or parenteral 5-Fluorouracil (5-FU) plus leucovorin in patients with metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Sizer, B. [2 ]
Makris, A. [1 ]
Barone, C. [3 ]
Bordonaro, R. [4 ]
Hausmaninger, H. [5 ]
Steger, G. [6 ]
Aloe, A. [7 ]
Peeters, O. [7 ]
Donato, B. [7 ]
机构：
[1] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[2] Essex Cty Hosp, Colchester, Essex, England
[3] Univ Cattolica, Rome, Italy
[4] Osped S Luigi, Catania, Italy
[5] Salzburg Hosp, Salzburg, Austria
[6] Med Univ, Vienna, Austria
[7] Bristol Myers Squibb Pharmaceut Res Inst, Braine Lalleud, Belgium
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [31] Randornised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer
    Nogué, M
    Salud, A
    Batiste-Alentorn, E
    Saigí, E
    Losa, F
    Cirera, L
    Méndez, M
    Campos, JM
    Galan, A
    Escudero, P
    Arcusa, A
    Manzano, H
    de Mendizábal, EV
    de Olaguer, JP
    Boleda, M
    Guasch, I
    Vicente, P
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) : 2241 - 2249
  • [32] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [33] A multicenter phase II study of "adjuvant" bi-weekly Irinotecan, infusional 5-fluorouracil (5FU) and leucovorin (LV) with oral tegafur/uracil (UFT) following resection of colorectal hepatic metastases.
    Kono, T
    Ebisawa, Y
    Chisato, N
    Asama, T
    Tomita, I
    Yamamoto, Y
    Ohe, N
    Ayabe, T
    Ashida, T
    Kasai, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 285S - 285S
  • [34] Economical evaluation of raltitrexed versus fluorouracil plus leucovorin (5-FU + LV) for treatment of advanced colorectal cancer
    Vorobyov, P
    Sura, M
    Avxentieva, M
    Papsheva, V
    VALUE IN HEALTH, 2002, 5 (06) : 538 - 538
  • [35] A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer
    Mackay, HJ
    Hill, M
    Twelves, C
    Glasspool, R
    Price, T
    Campbell, S
    Massey, A
    Macham, MA
    Uzzel, M
    Bailey, SM
    Martin, C
    Cunningham, D
    ANNALS OF ONCOLOGY, 2003, 14 (08) : 1264 - 1269
  • [36] A randomised phase II study comparing irinotecan (IRI) plus leucovorin (LV) and 5-fluorouracil (5FU) versus IRI-LV-5FU followed be oxaliplatin (OXA) plus LV-5FU in patients with previously untreated metastatic colorectal cancer (CRC).
    Kalofonos, H. P.
    Papakostas, P.
    Aravantinos, G.
    Papadimitriou, C.
    Pentheroudakis, G.
    Varthalitis, I.
    Tsavdaridis, D.
    Syrigos, K.
    Kosmidis, P.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 166S - 166S
  • [37] Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer
    Yang, TS
    Wang, JY
    Tang, RP
    Hsu, KC
    Chen, JS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (09) : 352 - 357
  • [38] A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nabpaclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer
    Vincent, Picozzi
    Vaibhav, Sahai
    Diane, Simeone
    Caio, Rocha Lima
    Allyson, Ocean
    Philip, Philip
    Wasif, Saif
    Aparna, Kalyan
    Michael, Ondovik
    Jack, Shiansong Li
    Chrystal, Louis
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Koji Okabayashi
    Hirotoshi Hasegawa
    Yoshiyuki Ishii
    Takashi Endo
    Hiroki Ochiai
    Tetsuro Kubota
    Yuko Kitagawa
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 501 - 507
  • [40] A prospective randomized phase III trial of adjuvant chemotherapy with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Greil, R.
    Tschmelitsch, J.
    Steger, G.
    Jakesz, R.
    Gnant, M.
    Hofbauer, F.
    Rabl, H.
    Thaler, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345